Kidney Transplantation: A Pharmacist-Focused Discussion of Common Clinical Issues Related to Comorbidities, Renal Function, and Organ Rejection

A. Scott Mathis, PharmD
Published Online: Friday, January 18, 2013
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Kidney Transplantation: A Pharmacist-Focused Discussion of Common Clinical Issues Related to Comorbidities, Renal Function, and Organ Rejection

A. Scott Mathis, PharmD

Administrative Director
Pharmacy and Medication Use
Pharmacy Department
Monmouth Medical Center
Long Branch, NJ



Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose.

Faculty
A. Scott Mathis, PharmD

Pharmacy Times Office of Continuing Professional Education Planning Staff
Judy V. Lum, MPA, Ann C. Lichti, CCMEP, and Elena Beyzarov, PharmD

Pharmacy Times  Editorial Staff
Jennifer Whartenby and David Allikas

PTOCPE uses an anonymous peer reviewer as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.


Educational Objectives

Upon completion of this educational activity, participants should be able to:

  1. Examine clinical issues and common comorbidities facing patients with kidney transplant.
  2. Discuss the role and mechanism of action of currently available immunosuppressive regimens used in managing patients with kidney transplant.
  3. Explore adverse effect and interaction profiles of currently available immunosuppressive regimens.
  4. Differentiate between calcineurin inhibitors and newer agents used to prevent rejection in kidney transplant patients.
  5. Address the pharmacist's role in counseling patients on adverse effects and interactions of currently available immunosuppressive regimens.

Target audience: Pharmacists
Type of activity: Knowledge
Release date: January 12, 2013
Expiration date: January 12, 2015
Estimated time to complete activity: 3 hours
Fee: This lesson is free online

Click here to view this activity.


Related Articles
The 2014 Kantar Media Pharmacy Readership Survey finds Pharmacy Times is the top choice among pharmacists, and the publication rated first in several key demographics.
Pharmacists can learn about new drugs approved by the FDA in 2013, including clinical indications, mechanisms of action, interactions, adverse reactions, and dosing guidelines.
The medications may lower cholesterol levels in advanced chronic kidney disease patients, but they do not appear to reduce the number of cardiovascular events and may interact with other drugs the patients are taking.
Latest Issues
$auto_registration$